{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:10:03Z","timestamp":1751433003416,"version":"3.41.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400171"],"award-info":[{"award-number":["82400171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Endothelial progenitor cells (EPCs) play a critical role in vasculogenesis and vascular repair, but their clinical application is hindered by challenges such as cell purity, quantity, and reliance on fetal bovine serum (FBS). This study developed an animal-free system for isolating, induction, and expanding EPCs from the human placenta, evaluating their potential for wound repair.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Mononuclear cells (MNCs) were isolated from full-term placenta and induced into EPCs using an animal-free medium supplemented with bFGF, IGF, and VEGF. EPCs were characterized by flow cytometry for markers CD133, CD34, and VEGFR2, while CD31 and CD45 served as negative markers. Functional assays, including Ac-LDL uptake, migration, and tube formation, confirmed EPC properties. The wound-repair potential was assessed in a mouse model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The induced EPCs exhibited high purity (&gt;\u200995%) and expressed CD133, CD34, and VEGFR2 while being negative for CD31 and CD45. The system yielded 1\u2009\u00d7\u200910\u2078 EPCs from 10\u00a0g of placental tissue, demonstrating high proliferative capacity. Functional assays confirmed robust tube formation, migration, and Ac-LDL uptake in vitro. In vivo, EPCs significantly enhanced wound repair.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In conclusion, human placenta-derived EPCs cultured in an animal-free system displayed high purity, self-renewal capacity, and functional efficacy, making them a promising cell source for therapeutic applications, particularly in wound repair.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40659-025-00625-2","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:38:28Z","timestamp":1751431108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human placenta-derived endothelial progenitor cells: an animal-free culture system for efficient expansion"],"prefix":"10.1186","volume":"58","author":[{"given":"Shengnan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengrou","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-8965","authenticated-orcid":false,"given":"Lingyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"625_CR1","doi-asserted-by":"publisher","first-page":"108315","DOI":"10.1016\/j.pharmthera.2022.108315","volume":"241","author":"X Shi","year":"2023","unstructured":"Shi X, Seidle KA, Simms KJ, Dong F, Chilian WM, Zhang P. Endothelial progenitor cells in the host defense response. Pharmacol Ther. 2023;241:108315.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"625_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/ars.2010.3872","volume":"15","author":"C Alev","year":"2011","unstructured":"Alev C, Ii M, Asahara T. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal. 2011;15(4):949\u201365.","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"625_CR3","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/stem.745","volume":"29","author":"T Asahara","year":"2011","unstructured":"Asahara T, Kawamoto A, Masuda H. Concise review: Circulating endothelial progenitor cells for vascular medicine. Stem Cells. 2011;29(11):1650\u20135.","journal-title":"Stem Cells"},{"issue":"5\u20136","key":"625_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2119\/molmed.2009.00032","volume":"15","author":"CJ Loomans","year":"2009","unstructured":"Loomans CJ, van Haperen R, Duijs JM, Verseyden C, de Crom R, Leenen PJ, et al. Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a Proinflammatory phenotype by hyperglycemia. Mol Med. 2009;15(5\u20136):152\u20139.","journal-title":"Mol Med"},{"issue":"1","key":"625_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1667\/RR15361.1","volume":"192","author":"MM Kim","year":"2019","unstructured":"Kim MM, Schlussel L, Zhao L, Himburg HA. Dickkopf-1 treatment stimulates hematopoietic regenerative function in infused endothelial progenitor cells. Radiat Res. 2019;192(1):53\u201362.","journal-title":"Radiat Res"},{"issue":"8","key":"625_CR6","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s12015-023-10617-y","volume":"19","author":"G Feugray","year":"2023","unstructured":"Feugray G, Miranda S, Le Cam Duchez V, Bellien J, Billoir P. Endothelial progenitor cells in autoimmune disorders. Stem Cell Rev Rep. 2023;19(8):2597\u2013611.","journal-title":"Stem Cell Rev Rep"},{"issue":"7","key":"625_CR7","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/term.2678","volume":"12","author":"E Bauman","year":"2018","unstructured":"Bauman E, Granja PL, Barrias CC. Fetal bovine serum-free culture of endothelial progenitor cells-progress and challenges. J Tissue Eng Regen Med. 2018;12(7):1567\u201378.","journal-title":"J Tissue Eng Regen Med"},{"issue":"4","key":"625_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s11262-020-01757-1","volume":"56","author":"SA Baylis","year":"2020","unstructured":"Baylis SA, Miskey C, Blumel J, Kaiser M, Kapusinszky B, Delwart E. Identification of a novel bovine copiparvovirus in pooled fetal bovine serum. Virus Genes. 2020;56(4):522\u20136.","journal-title":"Virus Genes"},{"key":"625_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biologicals.2016.12.009","volume":"46","author":"M Sadeghi","year":"2017","unstructured":"Sadeghi M, Kapusinszky B, Yugo DM, Phan TG, Deng X, Kanevsky I, et al. Virome of US bovine calf serum. Biologicals. 2017;46:64\u20137.","journal-title":"Biologicals"},{"issue":"1","key":"625_CR10","doi-asserted-by":"publisher","first-page":"10832","DOI":"10.1038\/s41467-024-55051-x","volume":"15","author":"T Xing","year":"2024","unstructured":"Xing T, Hu LJ, Zhao HY, Li CY, Wang ZK, Shen MZ, et al. Bone marrow endothelial progenitor cells remodelling facilitates normal hematopoiesis during acute myeloid leukemia complete remission. Nat Commun. 2024;15(1):10832.","journal-title":"Nat Commun"},{"key":"625_CR11","doi-asserted-by":"publisher","first-page":"1019657","DOI":"10.3389\/fimmu.2022.1019657","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Ye Y, Du Y, Xu Z, Yuan K, Wang Y, et al. EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation. Front Immunol. 2022;13:1019657.","journal-title":"Front Immunol"},{"key":"625_CR12","doi-asserted-by":"crossref","unstructured":"Ravishankar P, Zeballos MA, Balachandran K. Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood. J Vis Exp 2017(127).","DOI":"10.3791\/56021"},{"key":"625_CR13","first-page":"107","volume":"47","author":"P Szolomicka-Kurzawa","year":"2001","unstructured":"Szolomicka-Kurzawa P. [Improved method for delivery room collection and storage of human cord blood cells for grafting]. Ann Acad Med Stetin. 2001;47:107\u201324.","journal-title":"Ann Acad Med Stetin"},{"issue":"7","key":"625_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.cr.7290323","volume":"15","author":"CD Li","year":"2005","unstructured":"Li CD, Zhang WY, Li HL, Jiang XX, Zhang Y, Tang PH, et al. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation. Cell Res. 2005;15(7):539\u201347.","journal-title":"Cell Res"},{"issue":"3","key":"625_CR15","first-page":"196","volume":"15","author":"R Litwinowicz","year":"2018","unstructured":"Litwinowicz R, Kapelak B, Sadowski J, Kedziora A, Bartus K. The use of stem cells in ischemic heart disease treatment. Kardiochir Torakochirurgia Pol. 2018;15(3):196\u20139.","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"2","key":"625_CR16","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1161\/CIRCRESAHA.123.324082","volume":"135","author":"M Mori","year":"2024","unstructured":"Mori M, Sakamoto A, Kawakami R, Guo L, Slenders L, Mosquera JV, et al. CD163(+) macrophages induce Endothelial-to-Mesenchymal transition in atheroma. Circ Res. 2024;135(2):e4\u201323.","journal-title":"Circ Res"},{"issue":"1","key":"625_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13287-020-01799-0","volume":"11","author":"RM Amorim","year":"2020","unstructured":"Amorim RM, Clark KC, Walker NJ, Kumar P, Herout K, Borjesson DL, et al. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease. Stem Cell Res Ther. 2020;11(1):304.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"625_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/dmrr.1159","volume":"27","author":"M Li","year":"2011","unstructured":"Li M, Ho JC, Lai KW, Au KK, Xu A, Cheung BM, et al. The decrement in Circulating endothelial progenitor cells (EPCs) in type 2 diabetes is independent of the severity of the hypoadiponectemia. Diabetes Metab Res Rev. 2011;27(2):185\u201394.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"625_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ajpath.2010.11.037","volume":"178","author":"MW Laschke","year":"2011","unstructured":"Laschke MW, Giebels C, Nickels RM, Scheuer C, Menger MD. Endothelial progenitor cells contribute to the vascularization of endometriotic lesions. Am J Pathol. 2011;178(1):442\u201350.","journal-title":"Am J Pathol"},{"issue":"3","key":"625_CR20","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1182\/blood.V95.3.952.003k27_952_958","volume":"95","author":"M Peichev","year":"2000","unstructured":"Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by Circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95(3):952\u20138.","journal-title":"Blood"},{"issue":"4","key":"625_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.leukres.2006.10.014","volume":"31","author":"D Ribatti","year":"2007","unstructured":"Ribatti D. The discovery of endothelial progenitor cells. An historical review. Leuk Res. 2007;31(4):439\u201344.","journal-title":"Leuk Res"},{"issue":"2","key":"625_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2174\/1871530315666150316121956","volume":"15","author":"M Shibuya","year":"2015","unstructured":"Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets. 2015;15(2):135\u201344.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"625_CR23","doi-asserted-by":"crossref","unstructured":"Duong KL, Das S, Yu S, Barr JY, Jena S, Kim E et al., Identification of hematopoietic-specific regulatory elements from the CD45 gene and use for lentiviral tracking of transplanted cells. Exp Hematol. 2014, 42(9): 761\u2013772 e761-710.","DOI":"10.1016\/j.exphem.2014.05.005"},{"issue":"Suppl 1","key":"625_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/dmrr.2742","volume":"32","author":"SB Catrina","year":"2016","unstructured":"Catrina SB, Zheng X. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers. Diabetes Metab Res Rev. 2016;32(Suppl 1):179\u201385.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"625_CR25","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/bjh.15456","volume":"182","author":"XN Cao","year":"2018","unstructured":"Cao XN, Kong Y, Song Y, Shi MM, Zhao HY, Wen Q, et al. Impairment of bone marrow endothelial progenitor cells in acute graft-versus-host disease patients after allotransplant. Br J Haematol. 2018;182(6):870\u201386.","journal-title":"Br J Haematol"},{"issue":"4","key":"625_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1582-4934.2004.tb00474.x","volume":"8","author":"M Hristov","year":"2004","unstructured":"Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J Cell Mol Med. 2004;8(4):498\u2013508.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"625_CR27","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.3324\/haematol.2021.279756","volume":"107","author":"ZS Lyu","year":"2022","unstructured":"Lyu ZS, Tang SQ, Xing T, Zhou Y, Lv M, Fu HX, et al. The glycolytic enzyme PFKFB3 determines bone marrow endothelial progenitor cell damage after chemotherapy and irradiation. Haematologica. 2022;107(10):2365\u201380.","journal-title":"Haematologica"},{"key":"625_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mad.2016.04.002","volume":"159","author":"E Rurali","year":"2016","unstructured":"Rurali E, Bassetti B, Perrucci GL, Zanobini M, Malafronte C, Achilli F, et al. BM ageing: implication for cell therapy with EPCs. Mech Ageing Dev. 2016;159:4\u201313.","journal-title":"Mech Ageing Dev"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00625-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-025-00625-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-025-00625-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:38:30Z","timestamp":1751431110000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-025-00625-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1186\/s40659-025-00625-2","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"he study was approved by the Ethics Committee of Xuzhou Medical University (Project title: General-purpose enabled stem cell research and development; Name of the institutional approval committee: Xuzhou Medical University; Approval number: 202211S035; Date: 2022.10.13). The donors have provided written informed consent for the use of placental tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of financial interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}